Motilal Oswal Flags 9–11% Pharma Growth in India by FY 26; Recommends Five Stocks
Motilal Oswal Wealth Management projects India’s pharmaceutical sector to grow at 9–11% by fiscal 2026 and has spotlighted five pharma and healthcare stocks—Lupin, Mankind Pharma, Piramal Pharma, IPCA Labs, and…
Piramal Pharma open to partnerships in OTC; eyes further debt reduction
Piramal Pharma is open to partnerships in the over-the-counter (OTC) space in India as it charts out plans for organic growth and debt reduction. The company has been consistently reducing…